Aachen papers per year
Papers 539
-
Ruxolitinib Versus Best Available Therapy in Patients with Essential Thrombocythemia: Pre-Specified Interim Analysis of the Randomized Phase 2b Ruxobeat Clinical Trial of the German Study Group for Myeloproliferative Neoplasms (GSG-MPN)
Steffen Koschmieder, Susanne Isfort, Florian Heinrich Heidel, Andreas Hochhaus, Heiko Becker, Philipp Jakob Jost, +19 more
3citations -
Randomized Phase II Study of All-Trans Retinoic Acid and Valproic Acid Added to Decitabine in Newly Diagnosed Elderly AML Patients (DECIDER trial): Predictive Impact of TP53 Status
Heiko Becker, Claudia Schmoor, Olga Grishina, Dietmar Pfeifer, Dennis Zimmer, Martina Margrit Crysandt, +27 more
3citations -
Secondary-Type Mutations Do Not Impact the Favorable Outcome of NPM1-Mutated Acute Myeloid Leukemia Patients - Results from a Large Cohort of Intensively Treated Patients
Marius Bill, Jan‐Niklas Eckardt, Christian R. Rausch, Klaus Hans Metzeler, Karsten Spiekermann, Sebastian Stasik, +34 more
3citations -
Longitudinal Assessment of Transfusion Intensity in Patients with JAK Inhibitor-Naive or -Experienced Myelofibrosis Treated with Momelotinib in the Phase 3 Simplify-1 and Momentum Trials
Ruben A. Mesa, Andrew Charles Perkins, Yeow Tee Goh, María Laura Fox, Donal P. McLornan, Jeanne M. Palmer, +8 more
3citations -
Rusfertide or placebo plus current standard-of-care therapy for polycythemia vera: Durability of response and safety results through week 52 from the randomized controlled phase 3 VERIFY study2025 Blood conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Andrew Tucker Kuykendall, Aniket Bankar, Kristen Marie Pettit, Joseph James Shatzel, Alessandro Lucchesi, Valentín García‐Gutiérrez, +20 more
3citations -
Age Is a Crucial Determinant of GFRS with Incidence of Severe Chronic GVHD Reducing over Time in Haemopoietic Cell Transplantation for Transfusion Dependent Thalassaemia: Real World Data from 2010-2021. an Analysis of the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Working Party
DONATELLA BARONCIANI, Josu de la Fuente, Jacques‐Emmanuel Galimard, Arnaud Dalissier, Ashrafsadat Mousavi, Mehmet Akif Yesilipek, +13 more
3citations -
Selinexor Efficacy and Safety Are Independent of Renal Function in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL): A Post-Hoc Analysis from the Pivotal Phase 2b Sadal Study
Michael W. Schuster, Miguel Ángel Canales, Jason R. Westin, Josée M. Zijlstra, George Follows, Reem Karmali, +32 more
3citations -
Effect of Age on the Efficacy and Safety of Single Agent Oral Selinexor in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL): A Post-Hoc Analysis of the Sadal Pivotal Study
Michael W. Schuster, Miguel Ángel Canales, Jason R. Westin, Josée M. Zijlstra, George Follows, Reem Karmali, +32 more
3citations -
Tub-010, a Novel Antibody-Drug-Conjugate with Reduced Nonspecific Toxicity Profile Based on Tub-Tag Technology Widens the Therapeutic Window for the Treatment of CD30+ Malignancies
Marcus Gerlach, Saskia Schmitt, Philipp Cyprys, Marc‐André Kasper, Isabelle Mai, Maarten H. Vermeer, +5 more
3citations -
Polb 001, an Oral Broad-Spectrum Anti-Inflammatory with the Potential to Prevent Cytokine Release Syndrome (CRS)2023 Blood conference-abstract Immunology and Microbiology Immunotoxicology and immune responses cited by 3 patents
Emma J Searle, Liam Friel Tremble, Rakesh Popat, Digna T. de Bruin, Matthijs Moerland, Brendan Martin Buckley
3citations -
COVID-19 and Stem Cell Transplantation; Results from the Prospective Survey By the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation (EBMT) and the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH)
Per T Ljungman, Rafael de la Cámara, Małgorzata Mikulska, Gloria Tridello, Beatriz Aguado, Yves P. Beguin, +31 more
3citations -
Daratumumab Plus Lenalidomide, Bortezomib, and Dexamethasone (D-RVd) in Transplant-Eligible Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts): A Subgroup Analysis of Griffin
Larry Don Anderson, Jonathan L. Kaufman, Jacob P. Laubach, Douglas Weston Sborov, Brandi Reeves, Cesar Rodriguez, +21 more
3citations
Most active Aachen authors
-
Tim H. Brümmendorf 16,145 citations overall53 papers
-
Steffen Koschmieder 11,677 citations overall46 papers
-
Jens Panse 10,288 citations overall40 papers
-
Joost S.P. Vermaat 3,482 citations overall40 papers
-
Linda Köster 1,844 citations overall39 papers
-
Edgar Jost 3,752 citations overall31 papers
-
Dirk‐Jan Eikema 1,017 citations overall29 papers
-
Hendrik Veelken 10,266 citations overall25 papers
-
Fabian Beier 3,900 citations overall23 papers
-
Martina Margrit Crysandt 2,348 citations overall23 papers
-
Luuk A. Gras 5,079 citations overall21 papers
-
JESSICA T. VERMEULEN 10,466 citations overall20 papers
-
Liesbeth C. de Wreede 4,718 citations overall18 papers
-
Régis Peffault de Latour 20,463 citations overall14 papers
-
Antonio Maria Risitano 16,882 citations overall14 papers